Supplementary Figures S1 and S2: Association of MRD with Survival Outcomes in Myeloma Patients from the Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C. Anderson,Daniel Auclair, Gary J. Kelloff,Caroline C. Sigman,Hervé Avet-Loiseau,Ann T. Farrell,Nicole J. Gormley,Shaji K. Kumar,Ola Landgren,Nikhil C. Munshi,Michele Cavo,Faith E. Davies,Alessandra Di Bacco,Jennifer S. Dickey,Steven I. Gutman,Howard R. Higley,Mohamad A. Hussein,J. Milburn Jessup,Ilan R. Kirsch, Richard F. Little,Robert D. Loberg,Jens G. Lohr,Lata Mukundan,James L. Omel,Trevor J. Pugh, Gregory H. Reaman,Michael D. Robbins,A. Kate Sasser,Nancy Valente,Elena Zamagnicrossref(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要